Quick Search:         Advanced Search
Chinese Version
Online office
Journal Online
Download
Top
Links
许勇钢,麻柔,杨晓红,唐旭东,孙淑贞.益气补肾颗粒治疗对微小残留白血病患者CD4+CD8high T淋巴细胞和自然杀伤细胞的影响[J].,2010,30(6):571-574
益气补肾颗粒治疗对微小残留白血病患者CD4+CD8high T淋巴细胞和自然杀伤细胞的影响
Effect of Yiqi Bushen Granule on the Peripheral CD4+CD8high T-lymphocyte and Natural Killer Cell in Patients with Minimal Residual Leukemia
  
DOI:
中文关键词:  微小残留白血病  益气补肾颗粒  CD4+CD8highT淋巴细胞  自然杀伤细胞
英文关键词:minimal residual leukemia  Yiqi Bushen Granule  CD4+CD8high T lymphocytes  natural killer cell
基金项目:国家自然科学基金资助项目(No.30472284);首都医学发展科研基金(中医药)重大课题资助项目(No.I-1)
Author NameAffiliation
XU Yong-gan 中国中医科学院西苑医院 
MA Rou 中国中医科学院西苑医院 
YANG Xiao-hong 中国中医科学院西苑医院 
唐旭东 中国中医科学院西苑医院 
孙淑贞 中国中医科学院西苑医院 
Hits: 1956
Download times: 800
中文摘要:
      目的探讨益气补肾颗粒治疗后CD4+CD8highT淋巴细胞的变化及其对微小残留白血病(mini-mal residual leukemia,MRL)预后的意义。方法用多参数流式细胞技术比较分析36例MRL患者应用益气补肾颗粒治疗前后CD4+CD8 highT淋巴细胞亚群和自然杀伤细胞(NK细胞)改变。结果 (1)MRL患者3年持续完全缓解率、生存率分别为75.0%、80.5%,5年持续完全缓解率、生存率分别为63.9%、72.2%。(2)与治疗前比较,治疗后的MRL的CD4+CD8highT淋巴细胞百分率(%)和绝对值显著上升(P<0.01);(3)与治疗前比较,治疗后MRL的NK细胞百分率(%)和绝对值均显著上升(P<0.05,P<0.01)。结论益气补肾颗粒可能通过调节机体自身免疫功能,提高CD4+CD8highT和NK细胞的绝对数量,杀伤或抑制体内残存白血病细胞,延长MRL患者的无病生存期。
英文摘要:
      Objective To explore the effect of Yiqi Bushen Granule (YBG) on CD4+CD8high T lymphocyte in patients with minimal residual leukemia (MRL) and to probe its prognosis after treatment. Methods The changes of CD4+CD8highT lymphocyte subgroup and natural killer (NK) cells in 36 patients (16 males and 20 females) received long-term (>3 months) YBG therapy before and after treatment were analyzed using multi-parameter flow cytometry and controlled by those in 34 healthy persons (19 males and 15 females). Results The 3-year and 5-year complete remission rates in MRL patients were 75.0% and 63.9%; their 3-year and 5-year survival rates were 80.5% and 72.2%,respectively; as compared with the baseline,the absolute value and percentage of CD4+CD8high T lymphocyte and NK cells were all significantly raised after treatment (P<0.05 or P<0.01). Conclusion YBG could prolong the disease-free survival in MRL patients by way of regulating the immune function of organism,elevating the amount of CD4+CD8high T lymphocyte and NK cells to kill or suppress the residual leukemic cell in body.
View Full Text  View/Add Comment  Download reader